Stifel Financial’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-499
| Closed | -$20.1K | – | 3285 |
|
|
2023
Q2 | $20.1K | Sell |
499
-641
| -56% | -$25.8K | ﹤0.01% | 3285 |
|
|
2023
Q1 | $82.6K | Buy |
1,140
+30
| +3% | +$2.17K | ﹤0.01% | 3201 |
|
|
2022
Q4 | $91.1K | Sell |
1,110
-39
| -3% | -$3.2K | ﹤0.01% | 3145 |
|
|
2022
Q3 | $109K | Buy |
1,149
+728
| +173% | +$69.1K | ﹤0.01% | 3096 |
|
|
2022
Q2 | $82K | Buy |
421
+10
| +2% | +$1.95K | ﹤0.01% | 3179 |
|
|
2022
Q1 | $96K | Sell |
411
-12
| -3% | -$2.8K | ﹤0.01% | 3260 |
|
|
2021
Q4 | $167K | Sell |
423
-13
| -3% | -$5.13K | ﹤0.01% | 3185 |
|
|
2021
Q3 | $195K | Buy |
436
+14
| +3% | +$6.26K | ﹤0.01% | 3140 |
|
|
2021
Q2 | $164K | Sell |
422
-10
| -2% | -$3.89K | ﹤0.01% | 3173 |
|
|
2021
Q1 | $155K | Buy |
+432
| New | +$155K | ﹤0.01% | 3072 |
|